These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 12486102)

  • 1. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity.
    Hibbs ML; Harder KW; Armes J; Kountouri N; Quilici C; Casagranda F; Dunn AR; Tarlinton DM
    J Exp Med; 2002 Dec; 196(12):1593-604. PubMed ID: 12486102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
    Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
    J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
    Chan VW; Lowell CA; DeFranco AL
    Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
    J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
    Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell-specific loss of Lyn kinase leads to autoimmunity.
    Lamagna C; Hu Y; DeFranco AL; Lowell CA
    J Immunol; 2014 Feb; 192(3):919-28. PubMed ID: 24376269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.
    Mayeux J; Skaug B; Luo W; Russell LM; John S; Saelee P; Abbasi H; Li QZ; Garrett-Sinha LA; Satterthwaite AB
    J Immunol; 2015 Sep; 195(5):1955-63. PubMed ID: 26209625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn-/- mice.
    Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB
    Eur J Immunol; 2013 Feb; 43(2):382-93. PubMed ID: 23169140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.
    Moon BG; Takaki S; Nishizumi H; Yamamoto T; Takatsu K
    Cell Immunol; 2004 Apr; 228(2):110-8. PubMed ID: 15219462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.
    Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T
    Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.
    Takeshita H; Taniuchi I; Kato J; Watanabe T
    Int Immunol; 1998 Apr; 10(4):435-44. PubMed ID: 9620599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
    Pao LI; Cambier JC
    J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.
    Chan VW; Meng F; Soriano P; DeFranco AL; Lowell CA
    Immunity; 1997 Jul; 7(1):69-81. PubMed ID: 9252121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.
    Li HL; Davis WW; Whiteman EL; Birnbaum MJ; Puré E
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6890-5. PubMed ID: 10359809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H; Crockford TL; Silver K; Rust N; Goodnow CC; Cornall RJ
    Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.